The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes

Growth Hormone and IGF Research

Volumn 15, Issue 4, 2005, Pages 304-310

  Hedman, Christina A ^a   Frystyk, Jan ^b   Fridell, Karin ^a   Jönsson, Anna ^a   Flyvbjerg, Allan ^b   Lindström, Torbjörn ^a   Arnqvist, Hans J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diet; IGF I; Protein; Type 1 diabetes

Indexed keywords

CREATININE; GHRELIN; GLUCOSE; GROWTH HORMONE BINDING PROTEIN; HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UREA;

ADULT; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSSOVER PROCEDURE; DIET RESTRICTION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPEN STUDY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; URINARY EXCRETION;

ADULT; BODY HEIGHT; BODY WEIGHT; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 1; DIETARY PROTEINS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PEPTIDE HORMONES; PREGNANCY PROTEINS; RADIOIMMUNOASSAY;

EID: 23244447226     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2005.06.013     Document Type: Article

References (48)

1. A.P. Hansen K. Johansen Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics Diabetologia 6 1970 27-33
2. T.J. Merimee D.F. Gardner J. Zapf E.R. Froesch Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus Diabetes 33 1984 790-793
3. S.A. Amiel R.S. Sherwin R.L. Hintz J.M. Gertner C.M. Press W.V. Tamborlane Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes Diabetes 33 1984 1175-1179
4. K. Tan R.C. Baxter Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age J. Clin. Endocrinol. Metab. 63 1986 651-655
5. D.B. Dunger C.L. Acerini IGF-I and diabetes in adolescence Diabetes Metab. 24 1998 101-107
6. P.M. Jehle D.R. Jehle S. Mohan B.O. Bohm Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients J. Endocrinol. 159 1998 297-306
7. B. Ekman F. Nyström H.J. Arnqvist Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes Eur. J. Endocrinol. 143 2000 305-310
8. C.A. Hedman J. Frystyk T. Lindström Residual β-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes J. Clin. Endocrinol. Metab. 89 2004 6305-6309
9. A. Hilding K. Brismar M. Degerblad M. Thorén K. Hall Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects J. Clin. Endocrinol. Metab. 80 1995 2646-2652
10. J. Frystyk T. Ledet N. Møller A. Flyvbjerg H. Ørskov Cardiovascular disease and insulin-like growth factor I Circulation 106 2002 893-895
11. L.E. Smith J.J. Kopchick W. Chen J. Knapp Essential role of growth hormone in ischemia-induced retinal neovascularization Science 276 1997 1706-1709
12. M.B. Grant T.J. Wargovich E.A. Ellis S. Caballero M. Mansor C.J. Pepine Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells: A potential treatment for restenosis? Circulation 89 1994 1511-1517
13. A. Flyvbjerg Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease Diabetologia 43 2000 1205-1223
14. A. Juul T. Scheike M. Davidsen J. Gyllenborg T. Jørgensen Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study Circulation 106 2002 939-944
15. M. Harrela Q. Qiao R. Koistinen High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men Horm. Metab. Res. 34 2002 144-149
16. H. Hanaire-Broutin B. Sallerin-Caute M.F. Poncet Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM Diabetologia 39 1996 1498-1504
17. A. Bereket C.H. Lang T.A. Wilson Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus Horm. Metab. Res. 31 1999 172-181
18. C.A. Hedman A.C. Orre-Pettersson T. Lindstrom H.J. Arnqvist Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes Clin. Endocrinol. (Oxf.) 55 2001 107-112
19. D.B. Grant J. Hambley J. Becker B.L. Pimstone Reduced sulphation factor in undernourished children Arch. Dis. Child. 48 1973 596-600
20. R.L. Hintz R. Suskind K. Amatayakul O. Thanangkul R. Olson Plasma somatomedin and growth hormone values in children with protein calorie malnutrition J. Pediatr. 92 1978 153-156
21. K.E. Bornfeldt H.J. Arnqvist B. Enberg L.S. Mathews G. Norstedt J Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues Endocrinology 122 1989 651-656
22. D.S. Straus C.D. Takemoto Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and -II, IGF binding protein-2, and serum albumin gene expression in rat Endocrinology 127 1990 1849-1860
23. J.P. Thissen M.L. Davenport J.B. Pucilowska M.V. Miles L.E. Underwood Increased serum clearance and degradation of 125I-labeled IGF-I in protein-restricted rats Am. J. Physiol. 262 1992 E406-E411
24. B. Shapiro B.L. Pimstone Sulphation factor (somatomedin activity) in experimental protein malnutrition in the rat J. Endocrinol. 77 1978 233-240
25. M. Maes Y. Amand L.E. Underwood D. Maiter J.M. Ketelslegers Decreased serum insulin-like growth factor I response to growth hormone in hypophysectomized rats fed a low protein diet: Evidence for a postreceptor defect Acta Endocrinol. (Copenh.) 117 1988 320-326
26. W.L. Isley L.E. Underwood D.R. Clemmons Dietary components that regulate serum Somatomedin-C in humans J. Clin. Invest. 71 1983 175-182
27. G.B. Forbes M.R. Brown S.L. Welle L.E. Underwood Hormonal response to overfeeding Am. J. Clin. Nutr. 49 1989 608-611
28. P.A. Kontessis I. Bossinakou L. Sarika Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients Diabetes Care 18 1995 1233
29. Nordiska Näringsrekommendationer NNR (1996) 87-92.
30. Commission of the European Communities. Reports of the Scientific Committee for Food: Nutrient and energy intakes for the European Community. (Thity-first series of Food-Science and Techniques.) Luxembourg: Office for Official Publications of the European Communities (1992).
31. K.G. Alberti P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabetes Med. 15 1998 39-53
32. C.E. Kullberg A. Bergstrom B. Dinesen Comparisons of studies on diabetic complications hampered by differences in GHb measurements Diabetes Care 19 1996 726-729
33. J. Frystyk B. Dinesen H. Ørskov Non-competitive time-resolved immunofluorometric assays for determination of human IGF-I and IGF-II Growth Regul. 5 1995 169-176
34. J. Frystyk C. Skjærbæk C. Ørskov Free insulin-like growth factors (IGF-I and IGF-II) in human serum FEBS Lett. 348 1994 185-191
35. M. Westwood J.M. Gibson A.J. Davies R.J. Young A. White The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy J. Clin. Endocrinol. Metab. 79 1994 1735-1741
36. G.E. Krassas N. Pontikides T. Kaltsas Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease J. Clin. Endocrinol. Metab. 88 2003 132-135
37. J. Frystyk K. Højlund K.N. Rasmussen S.P. Jørgensen M. Wildner-Christensen H. Ørskov Development and clinical evaluation of a novel immunoassay for the binary complex of insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 in human serum J. Clin. Endocrinol. Metab. 84 2002 2324-2328
38. C. Skjærbæk A. Kaal J. Møller No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis J. Clin. Endocrinol. Metab. 83 1998 1206-1210
39. S. Fisker J. Frystyk L. Skriver E. Vestbo K.K.Y. Ho H. Ørskov A simple, rapid immunometric assay for determination of functional and growth hormone (GH)-occupied GH-binding protein in human serum Eur. J. Clin. Invest. 26 1996 779-785
40. U. Espelund T.K. Hansen K. Hojlund Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: Studies in obese and normal-weight subjects J. Clin. Endocrinol. Metab. 2 (Nov) 2004 Epub ahead of print
41. S. Rudberg G. Dahlqvist A. Aperia Indications that branched chain amino acids, in addition to glucagon, affect the glomerular filtration rate after a high protein diet in insulin-dependent diabetes Diabetes Res. 16 1991 101-109
42. F.Q. Nuttall M.C. Gannon A. Saeed K. Jordan H. Hoover The metabolic response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet J. Clin. Endocrinol. Metab. 88 2003 3577-3583
43. M.C. Gannon F.Q. Nuttall A. Saeed K. Jordan H. Hoover An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes Am. J. Clin. Nutr. 78 2003 734-741
44. P. Bang K. Brismar R.G. Rosenfeld K. Hall Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects J. Clin. Endocrinol. Metab. 78 1994 960-967
45. D. Rudman T.J. DiFulco J.T. Galambos R.B. Smith 3rd A.A. Salam W.D. Warren Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects J. Clin. Invest. 52 1973 2241-2249
46. S.D. Phinney Ketogenic diets and physical performance Nutr. Metab. (Lond.) 1 (1) 2004 2
47. J. Eisenstein S.B. Roberts G. Dallal E. Saltzman High-protein weight-loss diets: Are they safe and do they work? A review of the experimental and epidemiologic data Nutr. Rev. 60 2002 189-200
48. M.F. McCarty Vegan proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity Med. Hypoth. 53 1999 459-485